Exocrine pancreatic insufficiency (EPI) is diagnosed primarily through a stool test called fecal elastase, which measures how much of a specific digestive enzyme your pancreas is producing. A level below 200 µg/g suggests EPI, while levels below 100 µg/g provide strong evidence. Beyond this initial test, your doctor may use imaging, blood work, and occasionally more specialized tests to confirm the diagnosis and identify what’s causing it.
Who Should Be Tested
EPI doesn’t always announce itself with obvious symptoms, so knowing whether you’re at higher risk matters. The American Gastroenterological Association identifies two tiers of risk. High-risk conditions include chronic pancreatitis, recurring acute pancreatitis, pancreatic cancer, cystic fibrosis, and prior pancreatic surgery. If you have any of these, testing for EPI should be part of your routine care.
Moderate-risk conditions are less obvious but still warrant attention: celiac disease, Crohn’s disease affecting the duodenum, previous intestinal surgery, longstanding diabetes, and conditions that cause the stomach to overproduce acid. The classic symptoms that should prompt testing are greasy or oily stools (steatorrhea), unexplained weight loss, bloating, excessive gas, and deficiencies in fat-soluble vitamins (A, D, E, and K).
Fecal Elastase: The First-Line Test
Fecal elastase is the most widely recommended starting point because it’s noninvasive, inexpensive, and practical. Elastase is a digestive enzyme your pancreas produces that passes through the gut intact, so measuring it in stool gives a snapshot of pancreatic output. You provide a single stool sample, and the lab reports a concentration in micrograms per gram.
The interpretation breaks down like this:
- Above 500 µg/g: Normal pancreatic function
- 200 to 500 µg/g: A gray zone where the clinical significance is unclear
- 100 to 200 µg/g: Indeterminate for EPI
- Below 100 µg/g: Strong evidence of EPI
One important detail: the sample must be semi-solid or solid. Watery diarrhea dilutes the elastase concentration and can produce a falsely low reading. You can also take this test while already on pancreatic enzyme replacement therapy, since the test measures the enzyme your own pancreas makes, not the supplemental enzymes.
Blood Tests That Support the Diagnosis
Blood work alone can’t diagnose EPI, but it reveals the nutritional consequences that make the diagnosis more convincing. A complete blood count may show anemia, either from iron deficiency (which produces smaller-than-normal red blood cells) or from poor absorption of vitamin B-12 or folate (which produces larger-than-normal red blood cells). Checking serum levels of iron, B-12, folate, and fat-soluble vitamins helps build the case that your body isn’t absorbing nutrients properly.
Serum trypsinogen, another pancreatic enzyme measured in the blood, can also be useful. A level below 20 ng/mL is sensitive for detecting the fat malabsorption that comes with EPI. However, pancreatic enzyme levels in the blood are not reliable enough on their own to confirm or rule out the condition.
The 72-Hour Fecal Fat Test
Measuring fat in stool over a three-day period has long been considered the gold standard for confirming fat malabsorption, though it’s rarely used in routine practice because it’s cumbersome for both patients and labs. The process requires you to eat 100 grams of fat per day for the duration of the collection. Healthy individuals excrete less than 7 grams of fat per day, and a normal coefficient of fat absorption (the percentage of dietary fat your body actually takes in) is around 90%.
The AGA notes that quantitative fecal fat testing is generally not practical for routine clinical use. It’s most useful when fecal elastase results are borderline or when there’s a need to objectively confirm malabsorption before pursuing more invasive testing.
The D-Xylose Test: Separating Pancreatic From Intestinal Problems
If fecal fat results confirm you’re not absorbing fat properly, the next question is whether the problem lies in the pancreas or in the intestinal lining itself. The D-xylose test helps answer this. You drink a sugar solution, and your urine is collected afterward. In EPI, the intestinal lining is typically healthy, so you’ll absorb and excrete D-xylose normally. If urinary excretion is low, the problem is more likely damage to the gut wall itself, pointing toward conditions like celiac disease rather than pancreatic insufficiency.
Breath Tests
Two types of breath tests play a role in diagnosing EPI. A hydrogen breath test checks for carbohydrate malabsorption. You drink a lactose solution, and elevated hydrogen in your breath indicates the sugar is being fermented by bacteria rather than absorbed.
The 13C-mixed triglyceride breath test is more specific to pancreatic function. You consume a specially labeled fat, and the amount of labeled carbon dioxide you exhale reflects how well your pancreas is breaking down that fat. Pooled data from six studies show this test has a sensitivity of 84% and specificity of 87% for diagnosing EPI. It’s promising but not widely available in the United States.
Direct Pancreatic Function Testing
The most precise way to measure pancreatic output is a direct function test, typically the secretin stimulation test. This involves injecting secretin (a hormone that tells your pancreas to release digestive fluid) and then collecting fluid from the duodenum at 15, 30, 45, and 60 minutes. The fluid is analyzed for bicarbonate concentration, which reflects how well the pancreatic ducts are functioning.
A peak bicarbonate concentration above 80 mmol/L in any sample is normal. Values between 60 and 80 mmol/L suggest early chronic pancreatitis. Most patients with calcified chronic pancreatitis fall below 60 mmol/L, and anything below 50 mmol/L indicates severe exocrine insufficiency. This test is highly accurate but requires endoscopy and specialized equipment, so it’s reserved for cases where noninvasive tests are inconclusive.
Imaging: Finding the Cause
Imaging can’t tell you whether you have EPI, but it can reveal why you have it. CT scans and MRI help identify structural changes like calcifications, tumors, or duct abnormalities associated with chronic pancreatitis, the most common cause of EPI.
When more detail is needed, endoscopic ultrasound (EUS) and magnetic resonance cholangiopancreatography (MRCP) each have strengths. EUS has roughly twice the overall diagnostic yield of MRCP and is particularly strong at detecting biliary causes (gallstones or sludge) and potentially identifying early cancers. MRCP is better for spotting anatomical variants like pancreas divisum, a congenital difference in how the pancreatic ducts are arranged. For detecting cystic growths called IPMNs, the two perform equally well.
Ruling Out Conditions That Mimic EPI
Several conditions produce symptoms nearly identical to EPI, including bloating, diarrhea, fatty stools, and nutritional deficiencies. Small intestinal bacterial overgrowth (SIBO) is one of the most common mimics and can even coexist with EPI, making diagnosis trickier. If symptoms don’t improve with enzyme replacement therapy, testing for SIBO (typically with a breath test), celiac disease (through blood antibodies), Giardia infection, and liver disease is an important next step.
One thing worth noting: the AGA advises against using symptom improvement on a trial of pancreatic enzymes as a diagnostic tool. Some people feel better on enzymes for reasons unrelated to EPI, so a positive response doesn’t confirm the diagnosis.
What a Typical Diagnostic Path Looks Like
For most people, diagnosis starts with a fecal elastase test paired with blood work checking nutritional markers. If fecal elastase is clearly low (below 100 µg/g) and you have a known risk factor like chronic pancreatitis, that’s often enough to confirm EPI and begin treatment. When results fall in the gray zone, your doctor may add imaging to look for structural causes, or in some centers, proceed to a breath test or direct pancreatic function test. The 72-hour fecal fat collection is available as a backup but is rarely the first choice given how burdensome it is to complete.